Home -> Law Blog Directory -> Litigation Blogs -> How Appealing
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Litigation
: How Appealing"Justices Weigh Effect of F.D.A. Approval of Drug Labels on Suits in State Courts"
Today in The Washington Post, Jerry Markon reports that "High Court Case Looms Large for Drugmakers."
David G. Savage of The Los Angeles Times reports that "Supreme Court weighs lawsuits against drug makers; In Wyeth vs. Levine, the justices appear closely split on whether to uphold the Bush administration's policy that shields companies if the FDA has approved warning labels."
In The Wall Street Journal, Jess Bravin reports that "Justices Stake Out Middle Ground in Wyeth Case." The newspaper also contains an editorial entitled "Legal Side Effects: Can companies be sued even if they follow FDA instructions?"
In USA Today, Joan Biskupic and Julie Appleby report that "Drugmakers' lawsuit immunity tested; Court reviews strength of FDA label in amputee case."
And Michael Doyle of McClatchy Newspapers reports that "Businesses have much at stake in drug suit's outcome."
Full post as published by How Appealing on November 04, 2008 (boomark / email).
Selection of State Supreme Court Judges
How State Court Judges are Selected
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.
Medical Malpractice Suits Brings $37M Award
Medical Malpractice Suits Brings $37M Award
Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin.
The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...
Bristol-Myers Gets Preliminary Approval of $125 MillionPlavix Settlement
Bristol-Myers Gets Preliminary Approval of $125 MillionPlavix Settlement
Wachovia
Settles Telemarketing Suits for $200 Million
UnitedHealth
Settles Payment Suits for $350 Million

Courts - "In Drug Case, Justices to Weigh Right to Sue"
Supreme Court Set to Review Verdict Against Drug Maker
U.S. joins FCA suit against drug company accused of off-label marketing
U.S. Supreme Court to Hear Pharmaceutical Preemption Case
Emerging issues in state courts







